Ziox

Quick links to important sections

Ziox

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ziox

Ziox: Defining the Combination Debriding Agent

Ziox is a specialized multi-component topical combination drug primarily classified as an enzymatic debriding agent, formulated for direct application to the skin and localized lesions. It is distinct from simple antibacterial cleansers as it is designed to work both chemically and biologically. The medicine is intended for topical administration only and represents a approach to wound management used for preparing complicated wounds. Its classification as a debriding agent means its core function is to prepare compromised tissue surfaces for the healing process, a therapeutic class used in protocols for chronic and complex wound care.


Composition and Origin: The Role of Papain, Peroxide, and Chlorophyllin

Ziox features a hybrid-origin composition, combining the naturally derived enzyme Papain and the derived pigment Chlorophyllin with the synthetic compound Carbamide Peroxide. It is typically presented as a specialized ointment or solution. The active components ensure that Ziox functions beyond a simple antiseptic; it relies on the action of Papain, a proteolytic enzyme that assists in dissolving protein-rich debris. The combination of an enzymatic dissolver, a cleansing oxidant, and an anti-agglutinin differentiates Ziox formulations within the category of topical skin preparations.


General Therapeutic Purpose: Selective Wound Cleansing

The general therapeutic purpose of Ziox is to facilitate selective wound cleansing by aiding in the removal of non-viable tissue and proteinaceous material (slough). The drug helps the body perform enzymatic debridement, a critical step where dead tissue is dissolved and cleared away. This overall action is crucial because, by clearing debris from the wound bed, Ziox helps to create a clean, prepared environment for the viable tissue beneath to regenerate and heal naturally. A typical use scenario involves applying the product to a wound surface to aid in the controlled dissolution of non-living cellular material.

What side effects are possible with Ziox?

Possible Side Effects and Safety Information

The safety profile for Ziox (Carbamide Peroxide, Chlorophyllin, Papain), a topical enzymatic debriding agent, is predominantly characterized by localized reactions at the application site, as detailed in official regulatory documents. The most frequently documented reactions are associated with the drug's topical action on the tissue surface.


Adverse Reaction Classification

Adverse reactions are classified by frequency as follows:

  • Common Reactions (affecting up to 1 in 10 users): Local pain, burning sensation, and stinging at the application site. These effects may be more pronounced or common at the initiation of treatment and are typically transient.
  • Uncommon Reactions (affecting up to 1 in 100 users): Erythema (redness), Pruritus (itching), and irritation of the surrounding skin.

These local reactions are generally grouped under Skin and subcutaneous tissue disorders in official regulatory summaries.

Serious Adverse Reactions and Safety Constraints

Serious adverse events are rare. The principal serious risk documented is a systemic hypersensitivity reaction, classified under Immune system disorders, which requires immediate attention. Contraindication is mandatory for individuals with known hypersensitivity to Papain, Carbamide Peroxide, or Chlorophyllin.

Safety considerations concerning specific populations include the regulatory statement that safety and efficacy have not been established in children under 12 years of age. Furthermore, when the product is applied to extensive or deep wounds, the potential for systemic absorption of the active components is increased, a specific warning noted in official labeling. Concurrent use with heavy metal antiseptics (e.g., silver) or certain oxidizing agents must be avoided as these substances may inactivate the Papain enzyme, compromising the debriding action.

Overdose and Emergency Response

Overdose Manifestations and Signs

Overdose of Ziox, typically resulting from excessive application, prolonged use, or accidental ingestion, is primarily characterized by localized effects. Documented overdose presentations include exacerbated local skin irritation, often manifesting as a pronounced burning sensation or erythema (redness) at the application site. The core risk associated with Ziox is the potential for excessive debridement that can lead to severe localized chemical erosion of surrounding viable tissue. Accidental oral exposure may affect the gastrointestinal system, presenting with symptoms such as nausea and vomiting. Mucosal damage is also a documented risk following unintended contact with the eyes or oral cavity.

Required Emergency Actions and Management

Regulatory information dictates specific actions in the event of an overdose or accidental exposure. Seek immediate medical attention for all cases of accidental ingestion or contact with mucous membranes. Individuals must contact emergency services if extensive tissue erosion is observed or if systemic distress is reported. Management is officially described as symptomatic and supportive treatment. Required local measures include thorough irrigation of the affected area with copious amounts of water or saline. It is noted in regulatory documents that no specific systemic antidote is known for the active components.

Population Considerations

Pediatric accidental ingestion is listed as a specific consideration requiring immediate medical evaluation and subsequent hospital observation due to the heightened risk of mucosal damage in children.

Therapeutic Uses of Ziox

What Ziox Treats: Main Uses and Benefits

Ziox is relevant for managing the symptomatic burden of non-viable tissue in chronic, complex wounds. Debridement is a foundational component of wound management that helps prepare the wound bed for healing.

This medication is relevant for managing the symptom of impaired healing progression across conditions presenting with slow or non-progressive healing patterns. It is commonly used for conditions such as pressure ulcers, diabetic foot ulcers, and venous stasis ulcers. Ziox is specifically applied to address the presence of non-viable tissue burden, including firm, dark eschar and sticky, yellowish slough.

The use of this agent supports the overall therapeutic benefit of wound bed preparation by aiding in cleansing the tissue surface. This process assists in clearing the chronic accumulation of proteinaceous material, which is relevant for continued therapeutic management. The supportive action of tissue removal assists in easing the overall symptom load and supports comfort, particularly for elderly or fragile patients.


Quick Fact: Relief for Necrotic Tissue Burden Ziox provides the therapeutic benefit of selective tissue removal, a supportive method that helps clear the structural barriers (like eschar and slough) that prevent the wound from moving toward closure.

Regulatory References

  1. NIH NCBI overview on Wound Debridement

Eligibility and Restrictions for Use

The eligibility for Ziox (Quetiapine) is strictly defined by government regulatory documents, including specific exclusions and conditional use populations.

Contraindicated Populations

Use is absolutely prohibited for elderly patients with dementia-related psychosis due to an officially documented increased risk of death. It is also contraindicated for patients with a known hypersensitivity to the drug substance and for those taking strong CYP3A4 inhibitors (e.g., ketoconazole, HIV-protease inhibitors) concomitantly.

Age and Comorbidity Restrictions

Population Group Regulatory Status
Pediatric Patients Safety and effectiveness are not established for children younger than 10 years of age.
Hepatic Impairment Requires conditional use, including a lower starting dose (e.g., 25 mg/day) and slow titration.
Pregnancy/Lactation Use is generally not recommended during breastfeeding, and the drug should only be used during pregnancy if the benefit outweighs the potential risk.
Geriatric Patients Lower starting doses and careful monitoring are required, distinguishing them as a special-use population.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Ziox, a topical enzymatic debriding agent, is strictly defined by its highly localized action and chemical composition. Interactions with other medicines are limited to topical pharmacodynamic incompatibility.

The primary documented interaction involves the chemical inactivation of the Papain enzyme component. Substances containing heavy metal ions can precipitate or neutralize the enzyme's proteolytic activity, resulting in a loss of the product's intended debriding function.


Interaction-Related Restrictions

The official interaction profile lists specific categories of agents that must not be co-administered with Ziox on the same area of skin. This prohibition applies to topical preparations containing silver compounds, such as Silver Sulfadiazine and Silver Nitrate, and preparations containing mercury compounds (e.g., Thimerosal).

Due to this documented pharmacodynamic antagonism, a mandatory separation of application is required. This timing restriction ensures the active enzyme component of Ziox is not chemically rendered inactive by a simultaneously applied product, thereby preserving the product's function.

Because Ziox is formulated for local external application, the official profile notes the absence of documented systemic pharmacokinetic interactions (such as those mediated by CYP enzymes or drug transporters) with orally administered medicines.

Mechanism of Action

How Ziox Works

Ziox utilizes the synergistic actions of its three active components across distinct, localized pharmacodynamic domains to contribute to the alteration of the tissue surface.


Targeted Proteolysis and Protein Breakdown

This mechanism centers on the Papain enzyme, a cysteine protease, which initiates the hydrolysis of peptide bonds within denatured proteins (slough/eschar). The action is enhanced by the Urea component of Carbamide Peroxide, which softens and unfolds these non-viable proteins, increasing Papain's efficiency. This targeted enzymatic action results in the dissolution and liquefaction of protein matter, allowing access to the tissue underlying the denatured protein layer.


️ Oxidative Tissue Preparation and Cleansing Enhancement

The Carbamide Peroxide component dissociates to release Hydrogen Peroxide ( H2 O2), a local oxidizing agent. This process causes effervescence (foaming) that helps mechanically loosen and lift organic debris from the tissue surface. This cleansing domain supports the proteolytic action by physically clearing material, thereby facilitating the controlled clearance of surface material.


️ Microenvironment Stabilization and Protective Modulation

The mechanism includes Chlorophyllin, which acts as an anti-agglutinin to bind and sequester the protein fragments created during Papain's digestion, preventing their localized clumping. Furthermore, Chlorophyllin helps modulate pro-inflammatory signaling and scavenge excess Reactive Oxygen Species ( ROS) generated by the H2 O2. This combined action contributes to the stabilization of the local microenvironment by modulating inflammatory signaling and neutralizing excess Reactive Oxygen Species ( ROS) at the application site.

Dosage and Administration Information

How to Use Ziox: Official Administration Guidelines

Ziox is a topical combination agent with specific instructions governing its application, frequency, and duration.


Administration Scope

Ziox is administered exclusively via the topical route as either an ointment or a solution, designed for direct application only to the wound bed. The dosing regimen requires applying a thin layer of the preparation, sufficient to uniformly cover the entire non-viable tissue (slough and eschar). Standard application limits the treated surface area to wounds no larger than 50 cm^2 to align with established use conditions.


Frequency, Duration, and Preparation

Administration is scheduled once daily to three times daily, with the frequency often correlated to the required wound dressing change schedule. Ziox is intended for a short-term course of treatment, typically lasting 5 to 14 days, and should cease once the debridement phase is complete and non-viable tissue is cleared. Before each administration, the wound is cleansed with saline or water to remove residual medication and dissolved debris. A secondary occlusive or semi-occlusive dressing is required over the treated area.


Special Administration Rules

No dose adjustment is required for older adults or patients with mild to moderate renal or hepatic impairment, based on the drug’s intended local action and minimal systemic exposure. Procedural conditions strictly require application to be confined to the compromised tissue, avoiding the surrounding healthy skin.


Connection to the Overall Use Protocol

The guidelines establish a standardized, repetitive protocol focused on targeted surface use. This procedural structure dictates the precise steps—cleansing, confined topical application, and covering—that define the manner in which Ziox is administered, ensuring use is limited to the period necessary for debridement.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Ziox

Research Evidence for Cleansing Non-Viable Tissue (General Debridement)

Research has explored the primary function of Ziox and related agents in addressing non-viable tissue, which includes the slough and eschar that are part of the chronic wound process. Studies include systematic reviews and short-term randomized controlled trials (RCTs). The primary goal of these investigations was to measure outcomes related to the reduction in the amount of this non-viable tissue and the time intervals monitored regarding the wound surface status.

Studies monitored measured changes in non-viable protein material. The research provides insight into short-term changes, but the evidence base often relies on formulations that are similar to, but not exactly, the Ziox combination (Papain, Chlorophyllin, Carbamide Peroxide). What remains uncertain is the specific clinical profile of the triple combination when compared to other agents used in wound preparation.

Evidence from Studies in Pressure Ulcers (Stages II and III)

Research includes studies conducted during periods of increased symptom activity in pressure ulcers classified as Stage II and Stage III, focusing on older adults with co-existing conditions. The research examined outcomes related to the measured change in non-viable tissue over defined time periods in the specific patient groups studied. Evidence for this indication is limited, with sample sizes that were modest in some key studies, and findings were mixed due to variability in the specific formulation used and short follow-up durations.

Key Gaps and Areas of Research Uncertainty

Comparative data against other enzymatic or mechanical debridement options remain limited. One major limitation is that the evidence base relies heavily on research using similar, but not identical, formulations (e.g., papain with urea) rather than the precise combination of Ziox. Furthermore, the core research addresses the preparation of the wound bed, not long-term outcomes of complete healing.

Key Studies & References

  1. Enzymatic wound debridement - Database of Abstracts of Reviews of Effects (DARE) - NCBI
  2. Wound Debridement - StatPearls - NCBI Bookshelf
  3. Comparison of healing effectiveness of different debridement approaches for diabetic foot ulcers: a network meta-analysis of randomized controlled trials

Frequently Asked Questions (FAQ)

Common questions about Ziox (FAQ)

Q: What is the main purpose of Ziox?

Ziox is a product intended for use in wound debridement. According to official documents, its purpose is to help break down and remove non-viable tissue, which may include dead skin in various wounds, such as dermal ulcers and external burns.


Q: How quickly should I expect Ziox to start working?

Clinical data suggests that some patients may begin to notice signs of improvement in the wound area within a few days of beginning treatment. The timing of initial results can vary based on the specific condition being treated.


Q: Does Ziox cure the condition or just manage symptoms?

Ziox functions as a debriding agent by actively removing dead tissue. Official information states that while Ziox helps clear the wound bed, the full healing process depends on the underlying medical condition and overall patient care.


Q: Is Ziox considered a controlled substance?

According to the official classification by regulatory bodies, Ziox is not subject to the Controlled Substances Act and is not a controlled substance.


Q: What happens if I forget to take Ziox for a day?

Official patient information often describes a standard procedure for a missed dose: if remembered, application may proceed. If it is almost time for the next scheduled dose, the application is typically skipped. Official guidance indicates that extra medication should not be used to compensate for a missed application.


Q: Can Ziox be taken with basic over-the-counter pain relievers?

Official regulatory information indicates that Ziox is a topical medication with minimal absorption into the bloodstream, meaning it does not typically interact with oral over-the-counter pain relievers. However, topical pain relievers or other creams are advised to be avoided on the same area of skin unless specifically approved by a healthcare provider, as they could interfere with Ziox's active enzyme.


Q: Is it common for Ziox to cause changes in sleep patterns?

Changes in sleep patterns are generally not expected with Ziox use. Regulatory summaries indicate that because Ziox acts locally at the application site and has minimal systemic absorption, side effects that affect the entire body, such as altered sleep, are not typically reported.


Q: Why do some people say Ziox makes them feel more tired?

Ziox is a locally acting topical medication. Official safety summaries indicate that side effects affecting the whole body, such as systemic fatigue or tiredness, are generally not expected or reported due to the medication’s minimal absorption into the body.


Q: What is the drug class that Ziox belongs to?

According to official regulatory classifications, Ziox belongs to the drug class known as a topical debriding agent. This means it is a product intended to assist in the removal of non-viable tissue directly at the site of the wound.


Q: Are the side effects of Ziox usually temporary?

Yes, common side effects associated with Ziox are generally noted to be mild and temporary. Regulatory safety summaries indicate that local reactions, such as a burning sensation or transient irritation at the application site, are usually transient.


Q: How long does the effect of one dose of Ziox last?

Official dosing information indicates that Ziox is applied one to three times daily. This required frequency suggests the intended duration of effectiveness for each application period.


Q: What are the most common reasons a doctor would prescribe Ziox?

Official information describes Ziox as indicated for debridement, which is the removal of non-viable tissue in wounds. This includes applications for conditions such as dermal ulcers, external burns, and surgical wounds.


Q: Is Ziox associated with weight gain or weight loss?

Ziox is used locally and has minimal systemic absorption. Official safety summaries do not indicate an association between the topical use of Ziox and systemic side effects such as weight gain or weight loss.


Q: Is Ziox known to interact with herbal supplements?

No systemic interactions with oral herbal supplements are documented. However, regulatory warnings caution against the use of topical herbal products unless explicitly directed by a healthcare provider, as some ingredients may chemically interfere with Ziox’s enzyme component.


Q: What are the official warnings associated with Ziox?

Regulatory documents include official warnings regarding the use of Ziox. These warnings primarily identify application to actively bleeding wounds and use by patients with a known allergy to any component, such as Papain, papaya, or urea.


Q: Is Ziox safe to use while breastfeeding is generally discouraged?

Official product information states that it is not known whether the components of Ziox pass into breast milk. Official labeling states that use during breastfeeding is indicated only when a healthcare provider has determined the potential benefit justifies the potential risk.


Q: Does taking Ziox require regular blood tests?

Ziox is formulated for local action at the wound site, resulting in minimal systemic absorption. For this reason, official safety information indicates that Ziox does not typically require regular monitoring through blood tests.


Q: Does Ziox affect mood or mental alertness?

No effects on mood or mental alertness are expected with Ziox. As a topical drug with minimal systemic absorption, official safety summaries indicate the medication does not typically affect central nervous system functions.


Q: Is it possible to become dependent on Ziox?

Regulatory classification confirms that Ziox is not a controlled substance. Therefore, it is not associated with dependency.


Q: What common supplements or vitamins might interact with Ziox?

Oral supplements and vitamins are unlikely to interact with Ziox because of its minimal systemic absorption. However, official warnings caution that topical supplements, particularly those containing heavy metal ions (such as zinc), should be avoided as they can inactivate the main enzyme component of Ziox.


Q: Why is Ziox not recommended for people under 18?

Official regulatory information states that Ziox is not recommended for use in children under two years old. For those above two, use is generally restricted to situations where a healthcare provider has determined that the potential benefit outweighs the risk.


Q: What should I do if a side effect of Ziox is listed as 'serious'?

In the event of signs of a serious allergic reaction, such as hives, swelling of the face or throat, or difficulty breathing, official patient information indicates the necessity of seeking immediate medical attention. This is required for any severe side effect.


Q: Is the effectiveness of Ziox proven by long-term clinical trials?

Ziox is designed for a short-term course of treatment, typically lasting 5 to 14 days. Official documents indicate that due to its short-term nature, the effectiveness of Ziox is assessed through studies relevant to its defined period of use, not long-term clinical trials.


Q: Is Ziox safe for people with a history of heart issues?

Regulatory summaries indicate that Ziox is a locally acting topical agent. There are no known effects of the medication on heart function or blood pressure, as systemic absorption is minimal.


Q: What kind of monitoring is typically involved when taking Ziox?

Official safety precautions indicate that patient monitoring primarily involves observing the wound for signs of irritation or pain. If local irritation occurs, more frequent dressing changes may be necessary to remove the medication and excess wound fluid.


Q: Can Ziox be taken with antibiotics?

Oral antibiotics are generally safe to take with Ziox due to its minimal systemic absorption. However, regulatory warnings advise caution with topical antibiotics on the wound area unless a healthcare provider directs otherwise, as certain ingredients can chemically interfere with the product.


Q: Is Ziox an addictive substance?

Ziox is officially classified as a non-controlled substance. It is therefore not considered an addictive substance.


Q: What are the contraindications listed for Ziox in official documents?

Official documents state that Ziox is contraindicated if a known allergy to any component (such as Papain or urea) exists. It is also contraindicated for use on actively bleeding wounds or in patients with known bleeding disorders.


Q: Can Ziox cause changes to blood pressure readings?

Ziox is a topical medication with local action. According to official safety information, the medication has no known effects on blood pressure or general heart function when applied as directed.


Q: Does Ziox have a known 'Black Box Warning' in the US?

Regulatory documents for Ziox do not list a Black Box Warning, which is the strongest safety warning required by the FDA.


Q: Is Ziox a medication that requires refrigeration?

Official storage instructions indicate that Ziox does not require refrigeration, advising instead that the product should be stored in a dry place at a temperature not exceeding 30^circC (often room temperature) and protected from light.


Q: Why does the Ziox leaflet mention driving safety?

The mention of driving safety is a standard regulatory item. Since Ziox is a topical agent with minimal systemic effects, it is generally considered safe and is not expected to impair a person's ability to drive or operate machinery.


Q: How long after starting Ziox does it usually take to feel the full benefit?

Improvement in the wound area may be noticed quickly. However, the time required to achieve the full benefit, or complete debridement, typically falls within the expected 5 to 14 day course of treatment, depending on the specific wound's severity.


Q: Can Ziox interact with common anesthetic agents used in surgery?

Official interaction profiles document no systemic pharmacokinetic interactions for Ziox. Because it acts locally with minimal absorption into the bloodstream, interactions with general anesthetic agents used during surgery are not expected.

How should Ziox be stored and disposed of?

Ziox must be stored in the refrigerator between 36 F to 46 F (2 C to 8 C) and should be protected from light by remaining in its original packaging. It is essential to protect Ziox from freezing. If the product freezes, it must be discarded, particularly if it has been frozen more than once. Do not shake the product.

If the product is removed from the refrigerator, it can be kept at room temperature for up to four days. If left out longer than four days, the product must be thrown away. Do not attempt to save any unused portion from a prefilled syringe for later use.

Used prefilled syringes must be immediately thrown away after use in a specialized sharps disposal container. Do not recycle the syringe or dispose of it in household trash. Sharps containers must be kept out of the reach of children and disposed of according to community guidelines and local laws.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ziox found in:

A-Z Index: